Middle East and Asia Injectable Drugs Market
- 2026 年市場規模
- USD 615.44 Bn
- 2033 年預估規模
- USD 1,068.50 Bn
- 年複合成長率 CAGR
- 8.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Middle East and Asia Injectable Drugs Market, By Product Type (Pre-filled Syringes, Auto-injectors, Pre-filled Pens, Pre-mixed IV Bags, Others), By Drug Class (Anesthesia, Antibiotics, Antidotes, Antiemetic, Anti-infective, Anti-thrombolytic, Muscle Relaxant, Non Opioids, Opioids, Sedatives, and Others), By Route of Administration (Intramuscular (IM), Intravenous (IV), Subcutaneous (SC), and Others (Epidural and Intrathecal)), By End Users (Hospitals, Clinics, and Ambulatory Surgery Centers)
報告摘要
Injectable drug delivery is considered as the most effective route of administration for the effective delivery of drugs to the targeted site. Injectable delivery facilitates rapid absorption of drug from various route of administration such as subcutaneous, intravenous, and intramuscular. Injectable delivery increases the bioavailability of the drug at the systemic circulation. The increasing prevalence of chronic diseases, technological advancements, demand for individual therapy, awareness regarding drug metabolism among the population, and requirement of controlled drug release are the major factors driving the growth of the Middle East and Asia injectable drugs market.
Middle East and Asia injectable drugs market is estimated to be valued at US$ 4,15,000 Mn in 2021 and is expected to increase to US$ 7,23,164 Mn by 2028, witnessing a CAGR of 8.2% during the forecast period.
Market Dynamics
Increase in technology advancement, increasing government initiatives in healthcare sector of Middle East, innovations and ongoing R&Ds on injectable drug delivery systems and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the Middle East and Asia injectable drugs market.
As per the article Bevan Brittan, 2020, The Middle East is seeing a boom in healthcare sector. Aging populations, lengthening life expectations, and different lifestyle are the factors driving the market growth. The opportunities are leading to new models of care and out of hospital facilities because of the focus on prevention and not just simple treatment. Encompassing the primary, community and secondary care, the Saudi Arabia has embarked to build a new healthcare system.
Key features of the study
• This report provides in-depth analysis of the Middle East and Asia injectable drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Middle East and Asia injectable drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Kalbe Farma, Takeda pharmaceuticals Co. Ltd., Livzon Pharmaceutical Group, Inc., Sun Pharmaceutical Industries, Ltd., Pfizer, Inc., Sanofi, Novartis, Tabuk, Novo Nordisk, GlaxoSmithKline plc, AstraZeneca, and Gerresheimer AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Middle East and Asia injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Middle East and Asia injectable drugs market
Market Segmentation
• By Product Type (Revenue, USD Bn, 2021-2033)
o Pre-filled Syringes
Vaccines
Blood Stimulants
Biologics
Others
o Auto-injectors
o Pre-filled Pens
o Pre-mixed IV Bags
Sedative Products (Sedation)
Anesthesia Products (Anesthesia)
Pain Management Products (Post-operative analgesic pain management)
Chemotherapy Products (Chemotherapy)
Antibacterial Products (Infectious diseases)
Electrolyte and Nutrition Products (Electrolyte and Nutrition)
o Others
• By Route of Administration (Revenue, USD Bn, 2021-2033)
o Intramuscular (IM)
o Intravenous (IV)
o Subcutaneous (SC)
o Others (Epidural and Intrathecal)
• By Drug Class (Revenue, USD Bn, 2021-2033)
o Anesthesia
o Antibiotics
o Antidotes
o Antiemetic
o Anti-infective
o Anti-thrombolytic
o Muscle Relaxant
o Non Opioids
o Opioids
o Sedatives
o Others
• By End User (Revenue, USD Bn, 2021-2033)
o Hospitals
o Clinics
o Ambulatory Surgery Centers
• By Region (Revenue, USD Bn, 2021-2033)
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
• Key Players
o Kalbe Farma
o Takeda pharmaceuticals Co. Ltd.
o Livzon Pharmaceutical Group, Inc.
o Sun Pharmaceutical Industries, Ltd.
o Pfizer, Inc.
o Sanofi
o Novartis
o Tabuk
o Novo Nordisk
o GlaxoSmithKline plc
o AstraZeneca
o Gerresheimer AG
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Route of Administration
Market Snapshot, By Drug Class
Market Snapshot, By End User
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Middle East and Asia Injectable Drugs Market, By Product Type, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Pre-filled Syringes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Segment Trends
o Vaccines
o Blood Stimulants
o Biologics
o Others
o Auto-injectors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Pre-filled Pens
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Pre-mixed IV Bags
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
Segment Trends
o Sedative Products (Sedation)
o Anesthesia Products (Anesthesia)
o Pain Management Products (Post-operative analgesic pain management)
o Chemotherapy Products (Chemotherapy)
o Antibacterial Products (Infectious diseases)
o Electrolyte and Nutrition Products (Electrolyte and Nutrition)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
5. Middle East and Asia Injectable Drugs Market, By Route of Administration, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Intramuscular (IM)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Intravenous (IV)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Subcutaneous (SC)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Others (Epidural and Intrathecal)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
6. Middle East and Asia Injectable Drugs Market, By Drug Class, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Anesthesia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Antidotes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Antiemetic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Anti-infective
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Anti-thrombolytic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Muscle Relaxant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Non Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Sedatives
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
7. Middle East and Asia Injectable Drugs Market, By End User, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Ambulatory Surgery Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
8. Middle East and Asia Injectable Drugs Market, By Country, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Country Trends
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Asia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Kalbe Farma
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Takeda pharmaceuticals Co. Ltd.,
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Livzon Pharmaceutical Group, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Sun Pharmaceutical Industries, Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Pfizer, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Sanofi
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Novartis
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Tabuk
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Novo Nordisk
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
GlaxoSmithKline plc
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
AstraZeneca
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Gerresheimer AG
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們